CTCELLS

CTCELLS is a cutting-edge cancer diagnostics and drug development company, founded on the premise that effective cancer treatment requires tailored solutions for each individual. Leveraging Circulating Tumor Cell (CTC) liquid biopsy technology, CTCELLS leads the industry with its unique automation capabilities, enabling the isolation of all types of circulating tumor cells. With a strong focus on developing innovative cancer treatments, CTCELLS is dedicated to improving patient outcomes by matching cancer characteristics with the most suitable therapies, setting its sights on bringing hope to patients facing challenging cancer types. Join us in our mission to transform the landscape of cancer treatment.